Intra-Cellular Therapies, Inc.

JANE STREET GROUP, LLC

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/19/2025

Shares

132,909

Value ($000)

17,533

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/19/2025	17,533	0.0%	132,909	3/31/2025
2024 Q4	2/14/2025	22,308	0.0%	267,102	12/31/2024
2024 Q3	11/15/2024	21,575	0.0%	294,860	9/30/2024
2024 Q2	8/15/2024	32,958	0.0%	481,205	6/30/2024
2024 Q1	5/16/2024	3,640	0.0%	52,598	3/31/2024
2023 Q4	2/15/2024	11,955	0.0%	166,916	12/31/2023
2023 Q3	11/15/2023	985	0.0%	18,901	9/30/2023
2023 Q2	8/14/2023	10,052	0.0%	158,751	6/30/2023
2023 Q1	5/16/2023	5,829	0.0%	107,639	3/31/2023
2022 Q4	2/15/2023	3,849	0.0%	72,726	12/31/2022
2022 Q3	11/15/2022	4,396	0.0%	94,480	9/30/2022
2022 Q2	8/16/2022	1,527	0.0%	26,751	6/30/2022
2022 Q1	5/17/2022	1,967	0.0%	32,150	3/31/2022
2021 Q4	2/15/2022	2,118	0.0%	40,465	12/31/2021
2021 Q3	11/16/2021	624	0.0%	16,733	9/30/2021
2021 Q2	8/16/2021	227	0.0%	5,557	6/30/2021
2021 Q1	5/18/2021	407	0.0%	11,990	3/31/2021
2020 Q4	2/17/2021	2,562	0.0%	80,553	12/31/2020
2020 Q3	11/17/2020	1,772	0.0%	69,057	9/30/2020
2020 Q2	8/17/2020	5,859	0.0%	228,231	6/30/2020
2020 Q1	5/15/2020	239	0.0%	15,511	3/31/2020
2019 Q4	2/14/2020	543	0.0%	15,825	12/31/2019